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Abstract

Methionine aminopeptidases (MetAPs) are ubiquitous metallohydrolases that remove the N-terminal
methionine from nascent polypeptide chains. Although various crystal structures of MetAP in the presence of
inhibitors have been solved, the structural aspects of the product-bound step has received little attention. Both
perpendicular- and parallel-mode electron paramagnetic resonance (EPR) spectra were recorded for the MnIIloaded forms of the type-I (Escherichia coli) and type-II (Pyrococcus furiosus) MetAPs in the presence of the
reaction product l-methionine (l-Met). In general, similar EPR features were observed for both [MnMn(EcMetAPI)]−l-Met and [MnMn(PfMetAP-II)]−l-Met. The observed perpendicular-mode EPR spectra consisted of a six-line
hyperfine pattern at g = 2.03 (A = 8.8 mT) with less intense signals with eleven-line splitting at g = 2.4 and 1.7
(A = 4.4 mT). The former feature results from mononuclear, magnetically isolated MnII ions and this signal are 3-

fold more intense in the [MnMn(PfMetAP-II)]−l-Met EPR spectrum than in the [MnMn(EcMetAP-I)]−l-Met
spectrum. Inspection of the EPR spectra of both [MnMn(EcMetAP-I)]−l-Met and [MnMn(PfMetAP-II)]−l-Met at
40 K in the parallel mode reveals that the [Mn(EcMetAP-I)]−l-Met spectrum exhibits a well-resolved hyperfine
split pattern at g = 7.6 with a hyperfine splitting constant of A = 4.4 mT. These data suggest the presence of a
magnetically coupled dinuclear MnII center. On the other hand, a similar feature was not observed for the
[MnMn(PfMetAP-II)]−l-Met complex. Therefore, the EPR data suggest that l-Met binds to [MnMn(EcMetAP-I)]
differently than [MnMn(PfMetAP-II)]. To confirm these data, the X-ray crystal structure of [MnMn(PfMetAPII)]−l-Met was solved to 2.3 Å resolution. Both Mn1 and Mn2 reside in a distorted trigonal bipyramidal geometry,
but the bridging water molecule, observed in the [CoCo(PfMetAP-II)] structure, is absent. Therefore, l-Met
binding displaces this water molecule, but the carboxylate oxygen atom of l-Met does not bridge between the
two MnII ions. Instead, a single carboxylate oxygen atom of l-Met interacts with only Mn1, while the N-terminal
amine nitrogen atom binds to M2. This l-Met binding mode is different from that observed for l-Met binding
[CoCo(EcMetAP-I)]. Therefore, the catalytic mechanisms of type-I MetAPs may differ somewhat from type-II
enzymes when a dinuclear metalloactive site is present.

Methionine aminopeptidases (MetAPs) are ubiquitous enzymes that are responsible for the removal of Nterminal methionine residues from newly synthesized polypeptide chains (1−5). While the rationale for the
removal of the initiator methionine remains unclear, several explanations have been proposed (4). Some involve
the facilitation of further processing after excision of the N-terminal group such as removal of signal sequences if
present, proteolytic cleavage to generate shorter peptides, and/or the covalent attachment of residues and
blocking groups such as acetyl and myristoyl groups (3). MetAPs are, therefore, one of the key cellular enzymes
involved in protein maturation. Deletion of the gene encoding for MetAPs has been shown to be lethal
to Escherichia coli, Saccharomyces cerevisiae, and Salmonella typhimurium, indicating that the activity of MetAP
is essential for cell growth and survival (6−8). The importance of understanding the catalytic mechanism of
MetAPs is underscored by the recent observation that MetAPs are the target for antiangiogenesis drugs, one of
which is in third stage clinical trials (9, 10). Thus, the design of mechanism-based inhibitors is critically important
in the development of drugs that prevent tumor vasculature formation, growth, and proliferation.
On the basis of sequence alignment and X-ray crystallography data, MetAPs have been divided into two classes
(types I and II), distinguished by an extra 62 amino acid helical subdomain inserted within the C-terminal domain
in type-II enzymes, of unknown function (11). Bacteria have only type-I MetAPs, while archaea contain only type
II. In contrast, eukaryotes contain both type-I and type-II MetAPs (1). The type-I MetAPs from E. coli (EcMetAPI)1 and Staphylococcus aureus (SaMetAP-I) and the type-II MetAPs from Pyrococcus furious (PfMetAP-II)
and Homo sapiens (HsMetAP-II) have been crystallographically characterized and shown to contain homologous
catalytic domains that contain two metal ions coordinated by strictly conserved residues: two glutamates, two
aspartates, a histidine, and two water molecules (12−16). Although crystallographic analyses together with
sequence comparisons initially led to the supposition that all MetAPs were cobalt-dependent dinuclear
hydrolases, recent work has questioned the validity of this assumption (17−20). It has been shown
that EcMetAP-I and PfMetAP-II can be fully activated by a single equivalent of CoII, even though both enzymes
can incorporate 2 equiv of CoII (19, 20). However, the two metal-binding affinities differ by over 3 orders of
magnitude, suggesting that MetAPs are mononuclear hydrolases in vivo (19). The higher affinity, catalytically
relevant divalent metal-binding site has been assigned to the histidine-containing site based on 1H NMR (19) and
EXAFS (21) data.
MetAPs can be activated to different degrees by several first-row divalent transition-metal ions, which has
raised the question regarding the identity of the physiologically relevant metal. Walker et al. suggested that
ZnII is the physiologically relevant metal for the yeast MetAP-I because the enzyme was maximally activated with

zinc in the presence of 1 mM EDTA and glutathione (17). In contrast, in vitro activity assays and whole-cell metal
analyses by D'souza et al. (18) suggested that FeII or MnII is the in vivo metal ion for EcMetAP-I. Iron has also
been shown to maximally activate PfMetAP-II and provides a particularly active enzyme form at 80 °C, the
physiologically relevant temperature for P. furious (20). This observation suggests a physiological role for
FeII in PfMetAP-II. In more recent studies, the in vivo inhibition of HsMetAP-II by two competitive inhibitors, one
of which is specific for MnII-loaded HsMetAP-II, was characterized and these data suggested that MnII is the
active-site metal in vivo (22).
Because recent studies have highlighted manganese as a plausible candidate for the in vivo divalent metal ion
(22), it is important to provide insight into the mode of MnII binding to the active site of both type-I and type-II
MetAPs. In an effort to gain structural and mechanistic information on the MnII-loaded forms of MetAPs,
electron paramagnetic resonance (EPR) spectra of [MnMn(PfMetAP-II)] and [MnMn(EcMetAP-I)] were recorded
in the absence and presence of the product of hydrolysis, l-methionine (l-Met). In addition, the X-ray crystal
structure of the [MnMn(PfMetAP-II)]−l-Met complex was solved to 2.3 Å resolution. Differences between the
binding mode of l-Met to [MnMn(PfMetAP-II)] versus both [MnMn(EcMetAP-I)] and [CoCo(EcMetAP-I)] and their
mechanistic implications are discussed.

Materials and Methods
Protein Expression and Purification.
Recombinant EcMetAP-I (Arg175Gln) was expressed and purified as previously described (18). Purified EcMetAPI exhibited a single band on SDS−PAGE and a single symmetrical peak in matrix-assisted laser desorption
ionization−time-of-flight (MALDI−TOF) mass spectrometric analysis indicating Mr = 29 630 ± 10. Protein
concentrations for all experiments were estimated from the absorbance at 280 nm using an extinction
coefficient of 16 450 M-1 cm-1. Apo-EcMetAP-I samples were exchanged into 25 mM [4-(2-hydroxyethyl)-1piperazineethanesulfonic acid] (HEPES) at pH 7.5, containing 150 mM KCl (Centricon-10, Millipore Corp.).
PfMetAP-II was purified as previously reported (20). Purified PfMetAP-II exhibited a single band on SDS−PAGE
with a Mr of 33 000. Protein concentrations were estimated from the absorbance at 280 nm using an extinction
coefficient of 21 650 M-1 cm-1. Metal-free PfMetAP-II was prepared by concentrating the as-purified PfMetAP-II
to a volume of ∼5 mL after which EDTA was added to a final concentration of 10 mM. The resulting protein
solution was dialyzed against 25 mM HEPES (2 L, pH 7.5) containing 10 mM EDTA and 150 mM KCl at 4 °C for 2
days with two buffer changes per day. The protein solution was then dialyzed against chelexed (Chelex-100
Column) 25 mM HEPES buffer (2L, pH 7.5) containing 150 mM KCl for 3 days against two buffer changes per day.
The resulting PfMetAP-II was inactive and was found to contain no detectable metal ions via inductively coupled
plasma−atomic emission spectrometry (ICP−AES).

Enzymatic Assay.
EcMetAP-I was assayed for catalytic activity with the tetrapeptide MGMM as the substrate (8 mM) using a highperformance liquid chromatography (HPLC) method as previously described (19). This method is based on the
spectrophotometric quantitation of the reaction product GMM following separation on a C8 HPLC column
(Phenomenex, Luna; 5 m, 4.6 × 25 cm). The kinetic parameter v (velocity) was determined at pH 7.5 by
quantifying the tripeptide GMM at 215 nm in triplicate. The inhibition constant (Ki) for l-Met (from Sigma, St.
Luis, MO) was obtained by measuring the activity of 1 μM of MnII-loaded PfMetAP-II with 1−30 mM MGMM in
the presence of 0−200 mM l-Met. These data were fit to the nonlinear competitive inhibition equation, using
Sigma Plot Software.

Spectroscopic Measurements.
Electronic absorption spectra were recorded on a Hewlett−Packard (8453) diode array spectrophotometer. Lowtemperature EPR spectroscopy was performed using a Bruker ESP-300E spectrometer equipped with an ER 4116
DM dual mode X-band cavity and Oxford Instruments ESR-900 helium flow cryostat. Background spectra,
recorded on a buffer sample, were aligned with and subtracted from all experimental spectra. EPR spectra were
recorded at microwave frequencies of ∼9.65 GHz, and precise microwave frequencies were recorded for
individual spectra to ensure precise g alignment. All spectra were recorded at 100 kHz modulation frequency,
while other EPR running parameters are specified in the figure captions for individual samples. The apoEcMetAP-I and PfMetAP-II enzymes were incubated with substoichiometric amounts of MnII to suppress the
isotropic signal from [Mn(H2O)6]2+ and also to observe signals from the MnII-bound forms of MetAPs. Computer
simulations were performed using XSophe (Bruker Biospin) (23).

Crystallization, Data Collection, and Refinement.
[MnMn(PfMetAP-II)]−l-Met was crystallized by sitting drop vapor diffusion at 21 °C (12). The crystals, of an
average size of 0.3 × 0.3 × 0.4 mm3, were obtained within 30 days by mixing equal volumes (3 μL each) of 20 mg
mL-1 of the [MnMn(PfMetAP-II)] protein solution (containing 30 mM l-Met in 20 mM potassium acetate buffer at
pH 4.5) and the reservoir solution containing 20% ethanol in 0.1 M Tris buffer at pH 8.5.
The [MnMn(PfMetAP-II)]−l-Met crystals belong to space group P64 with unit cell parameters a = b = 112.01 Å
and c = 122.96 Å. Prior to data collection, the crystals were equilibrated for 5 min in a mother liquor solution
containing 30% glycerol as a cryoprotectant. The crystals were flash-cooled in liquid nitrogen on rayon loops,
and data collection was performed under a continuous nitrogen stream at ∼100 K at the Stanford Synchrotron
Radiation Laboratory (SSRL) beamline 9-1 (λ = 1.5418 Å). Reflections were integrated using MOSFLM (24) and
scaled with SCALA of the CCP4 suite of programs (25) (Table 1). The 208 524 total reflections measured for
[MnMn(PfMetAP-II)]−l-Met were reduced to 38 795 unique reflections representing 99.7% of complete data to
2.3 Å resolution (Table 1).
Table 1: Data and Refinement Statistics of the [MnMn(PfMetAP-II)]−l-Met Structurea
crystals
space group
cell dimensions

PfMetAP-II
P64
a = 112.01 Å
b = 112.01 Å
c = 122.96 Å
resolution (Å)
30.0−2.30
completeness (%) (last cell) 99.7 (99.9)
observed reflections
208 524
unique reflections
38 795
I/σ
4.4 (2.6)
Rmerge (%)b
11.0 (33.5)
protein nonhydrogen atoms 4620
solvent molecules
325
Mn ions
4.0
Rcryst (%)c
21.5
c
Rfree (%)
25.2
bond lengths (Å)
0.011
bond angles (deg)
2.2
Ramachandran analysis
most favored regions (%)
92.2

additional allowed regions
7.4
generously allowed regions 0.4
disallowed regions
0.0
a
Numbers in parentheses indicate values for the highest resolution bin.b Rmerge = ∑hkl∑i|Ii − 〈I〉/∑hkl∑i|〈I〉|,
where Ii is the intensity for the ith measurement of an equivalent reflection with indices h, k, and l.c Rcryst =
∑hkl||Fobs| − |Fcalc||/∑hkl|Fobs|, where Fobs denotes the observed structure-factor amplitude and Fcalc denotes the
structure-factor amplitude calculated from the model; 5% of the reflections were used to calculate bRfree.
The structure was determined by the molecular replacement method with AMORE (26, 27) using the
[CoCo(PfMetAP-II)] structure (PDB entry 1XGM) (12) as a search model. The search was carried out with the data
between 12.0 and 5.0 Å, and two molecules had a correlation coefficient of 70.2 (R = 31.8%). Solvent flattening
and 2-fold noncrystallographic averaging were employed to improve the quality of the electron-density map
(25). The model was improved through iterative model building using the program O (28). During refinement, a
bulk solvent correction allowed the inclusion of all low-resolution reflections and ∼5% of the data were
randomly selected for cross validation (29). Model bias was removed for the incorporation of Rfree calculation for
cross validation by randomization using the simulated annealing routine of CNS (29) with an annealing
temperature of 4000 K. Initial-position refinement of the rigid-body-refined model using 30.0−2.3 Å for the
[MnMn(PfMetAP-II)]−l-Met data followed by group B-factor refinement dropped the Rfree to 31.9% and Rcryst to
28.7%. During the majority of refinement, noncrystallographic symmetry restraints were applied to restrict
differences in symmetrically equivalent atoms. These restraints were released in the latter stages of refinement.
The final model has been refined to the full-resolution range of data (Table 1) to a current Rfree of 25.2%
and Rcryst of 21.5%. The crystal structure of [MnMn(PfMetAP-II)]−l-Met consists of all 590 possible protein
residues, 4 Mn ions, and 325 water molecules per symmetry unit cell (Table 2). PROCHECK (30) analysis indicates
that the model exhibits good geometry with a root-mean-square deviation from ideal bond lengths and angels
of 0.011 Å and 2.20° and with all residues of the model lying in the allowed regions of the Ramachandran plot
(Table 1).
Table 2: Selected Averaged Distances for the Active Site of [MnMn(PfMetAP-II)]−l-Met and the Analogous
Distances for [CoCo(EcMetAP-I]−l-Meta
A
B
average
Mn(1)−Mn(2)
3.34 3.45 3.4
Co(1)−Co(2)
3.3
Mn(1)−Asp93(Oδ2)
1.94 2.04 2.0
Co(1)−Asp108(Oδ1) 2.0
Mn(1)−His153(Nε2) 2.13 2.13 2.1
Co(1)−His171(Nε2) 2.1
Mn(1)−Glu187(Oε2) 2.12 2.04 2.1
Co(1)−Glu204(Oε2) 2.1
Mn(1)−Glu280(Oε2) 1.96 2.00 2.0
Co(1)−Glu235(Oε1) 2.0
Mn(2)−Asp82(Oδ1)
2.13 2.08 2.1
Co(2)−Asp97(Oδ1)
2.2
Mn(2)−Asp82(Oδ2)
2.00 2.08 2.0
Co(2)−Asp97(Oδ2)
2.3
Mn(2)−Asp93(Oδ1)
2.05 2.05 2.1
Co(2)−Asp93(Oδ2)
2.1
Mn(2)− Glu280(Oε2) 2.00 2.02 2.0
Co(2)− Glu235(Oε2) 2.2
Mn(2)−Met(N)
2.09 2.07 2.1
Co(2)−Met(N)
2.2
Mn(1)−Met(O)
1.91 1.93 1.9
Co(1)−Met(O)
2.0
Mn(2)−Met(O)
2.71 2.82 2.8
Co(2)−Met(O)
2.2
a
The distances for each molecule are reported separately (labeled A and B) as well as the average of the two
(rounded to the tenths place to be more in line with the anticipated coordinate for a structure at the current
resolution).

Results
Inhibition of [Mn(PfMetAP-II)] by l-Met.
The specific activity of MnII-loaded PfMetAP-II was determined at nine substrate concentrations (1−30 mM
MGMM) in the presence of 0−200 mM l-Met. These data were plotted as activity versus substrate concentration
and fit to a competitive inhibition equation using Sigma Plot software. l-Met was found to be a weak competitive
inhibitor of MnII-loaded PfMetAP-II with a Ki value of 150 ± 30 mM.

Electronic Absorption Spectroscopy.
The electronic absorption spectrum of CoII-loaded Pf MetAP-II reveals three maxima with λmax values of 525 nm
(ε525 = 72 M-1 cm-1), 562 nm (ε562 = 100 M-1 cm-1), and 590 nm (ε590 = 93 M-1 cm-1) (Figure 1A). These data are in
good agreement with previously published results (20). Upon the addition of 20 mM l-Met to CoIIloaded PfMetAP-II, the intensity of the observed peaks decreased by approximately 25% (Figure 1B). The molar
absorptivities further decreased after the addition of l-Met to a concentration of 120 mM, but the λmax did not
change (Figure 1C). The observed λmax values and their corresponding molar absorptivities are consistent with
the active-site CoII ion in the l-Met complex residing in a distorted pentacoordinate environment.

Figure 1 Electronic absorption spectrum of (A) [Co(PfMetAP-II)], (B) [Co(PfMetAP-II)] and 20 mM l-Met, and (C)
[Co(PfMetAP-II)] and 120 mM l-Met. All electronic absorption spectra were recorded with 1 mM (PfMetAP-II)
with 2 equiv of CoII added (25 mM HEPES at pH 7.5 and 150 mM KCl).

EPR Spectra of [MnMn(PfMetAP-II)] and [MnMn(EcMetAP-I)].
The EPR spectra of [MnMn(PfMetAP-II)] and [MnMn(EcMetAP-I)], recorded at 10 K, are essentially
indistinguishable (traces A and C of Figure 2) and are characteristic of mononuclear MnII, with geff = 2.03
and AI=5/2(55Mn) = 9 mT (31). Also evident in the spectra is a six-line pattern centered at g = 4.15 (166 mT)
with Aav(55Mn) ∼ 9.0 mT. This signal is often attributed to Δms = 2 transitions that are formally forbidden for
systems of high symmetry (32−34). Additional features were also observed at g = 5.1 (134 mT), g = 2.4 (290 mT),
and g = 1.6 (434 mT); these features were weak and poorly resolved at 10 K (traces A and C of Figure 2) but
increased in intensity at higher temperatures (traces B and D of Figure 2). Variable temperature studies (not
shown) indicated a Boltzmann-like temperature dependence for these features, suggestive of excitation of
higher energy doublets in a spin ladder, and second derivative EPR spectra (insets on trace B of Figure 2)
identified the multiline structure of these features with a splitting of 0.45 mT.

Figure 2 EPR spectra of [MnMn(EcMetAP-I)] (A and B) and [MnMn(PfMetAP-II)] (C and D). Spectra were recorded
with 0.4 mT modulation amplitude with microwave powers and temperatures, respectively, of 1 mW and 10 K
(A), 10 mW and 20 K (B), 0.1 mW and 10 K (C), and 10 mW and 20 K (D). The insets above trace B are second
derivatives of B (∂2χ/∂H2).
Parallel-mode (B0||B1) EPR spectra of [MnMn(PfMetAP-II)] and [MnMn(EcMetAP-I)] (Figure 3) were recorded at
various temperatures. At 5 K, the signals are dominated by an intense near-zero-field absorption at g ≥ 21
(traces A and B of Figure 3). These signals are likely to originate from one or more inter-Kramers' doublet fine
structure transitions for a mononuclear MnII center. Similar signals were observed for other MnII enzymes such
as bacteriophage λ protein phosphatase and arginase (35−38). The Δms = 2 half-field transitions are also
prominent, and there is some “bleed over” of the g ∼ 2 six-line pattern. Thus, at 5 K, all of the spectral features
in the parallel-mode signal can be attributed to mononuclear MnII. However, at higher temperatures (e.g., 40 K;
traces C and D of Figure 3), additional features become apparent. There is a minimum feature at geff = 4.2 (165
mT), which is suggestive of an S = 1 spin system, a peak at geff = 8.0 (85 mT), which suggests an S = 2 spin system,
a shoulder at geff = 12 (58 mT), and a broad feature extending out of the zero field that exhibits a minimum
at geff = 18 that could arise from either or both an S = 4 or 5 spin system (39). These features displayed complex,
Boltzmann-like temperature dependence, and although the signals could not be deconvoluted because of
overlap in both the spectral and temperature domains, their resonance positions and temperature
dependencies are consistent with them being due to non-Kramers' doublet transitions in an S = 0, 1, ..., 5 spin
ladder (40, 41). This, in turn, is completely consistent with two antiferromagnetically coupled MnII ions
exhibiting modest exchange coupling (J ≪ 50 cm-1). Strong support for this assignment comes from a clear
hyperfine pattern on the g = 8 feature with a hyperfine splitting of 4.4 mT (32, 38).

Figure 3 Comparison of high- and low-temperature parallel-mode spectra of [MnMn(PfMetAP-II)] and
[MnMn(EcMetAP-I)]. Parallel-mode spectra of 1 mM [MnMn(PfMetAP-II)] recorded at (A) 4.85 and (C) 40 K.
Parallel-mode spectra of 1 mM [Mn(EcMetAP-I)] recorded at (B) 5 and (D) 40 K. The applied EPR parameters
were as follow: 9.39 GHz, spectrometer frequency; 20 mW, microwave power; 0.4 mT, modulation amplitude;
and 2 mT s-1, sweep rate.

EPR Spectra of [MnMn(EcMetAP-I)]−l-Met and [MnMn(PfMetAP-II)]−l-Met.
Parallel- and perpendicular-mode spectra were recorded for both [MnMn(EcMetAP-I)] and [MnMn(PfMetAP-II)]
in the presence of the reaction product, l-Met. Figure 4 shows the perpendicular-mode spectra of
[MnMn(EcMetAP-I)]−l-Met and [MnMn(PfMetAP-II)]−l-Met at 40 K. Clearly, both spectra contain the same
spectral features as [MnMn(EcMetAP-I)] and [MnMn(PfMetAP-II)], although the intensities of the central six-line
pattern, because of mononuclear MnII, is markedly decreased. In addition, the hyperfine patterns observed in
the spectra of naked [MnMn(EcMetAP-I)] and [MnMn(PfMetAP-II)] (Figure 2B) are much better resolved in the lMet-bound species and are clearly visible in the first derivative (∂χ/∂H) traces (Figure 4). The observed hyperfine
pattern at 290 mT and a less intense pattern at 408 mT consists of eleven lines with approximate relative
intensities of 1:2:3:4:5:6:5:4:3:2:1 and a hyperfine coupling constant of ∼4.4 mT. This hyperfine pattern is
diagnostic for exchanged coupled MnII−MnII centers (32, 38, 39). The parallel-mode spectra of [MnMn(EcMetAPI)]−l-Met and [MnMn(PfMetAP-II)]−l-Met (Figure 5) are essentially indistinguishable from the spectra of the
unbound forms of [MnMn(EcMetAP-I)] and [MnMn(PfMetAP-II)], except that, as for the perpendicular-mode
spectra, the hyperfine patterns are better resolved in the l-Met-bound species (Figure 6).

Figure 4 EPR spectrum of 1 mM [MnMn(EcMetAP-I)]−l-Met (A) and [Mn(PfMetAP-II)]−l-Met (B) complexes.
These data were collected at 40 K using 20 mW, microwave power; 0.4 mT, modulation amplitude; and 2 mT s-1,
sweep rate. High-resolution scans of the region 220−320 mT at 40 K are shown as a “blow up” above each
spectrum. Inset, comparison of the g = 2 region. The signal at g = 2.03 of [Mn(EcMetAP-I)]−l-Met was multiplied
by 3. The EPR parameters were 20 mW, microwave power; 1 mT, modulation amplitude; and 2 mT s-1, scan rate.

Figure 5 Parallel-mode spectra of 1 mM [MnMn(PfMetAP-II)]−l-Met at (A) 4.85 and (C) 40 K and 1 mM
[MnMn(EcMetAP-I)]−l-Met at (B) 5 and (D) 40 K. The applied EPR parameters were as follow: 9.39 GHz,
spectrometer frequency; 20 mW, microwave power; 0.4 mT, modulation amplitude; and 2 mT s-1, sweep rate.

Figure 6 High resolution in parallel-mode EPR spectra of 1 mM [MnMn(PfMetAP-II)]−l-Met recorded at (A) 40
and (B) 70 K and 1 mM [MnMn(EcMetAP-I)]−l-Met recorded at (C) 40 and (D) 70 K. EPR-recording conditions
were as follows: 9.39 GHz, spectrometer frequency; 20 mW, microwave power; 1 mT, modulation amplitude;
and 2 mT s-1, scan rate.

X-ray Crystal Structure of [MnMn(PfMetAP-II)] with l-Met.
The X-ray crystal structure of [MnMn(PfMetAP-II)] complexed with the reaction product l-Met was solved to 2.3
Å resolution. The comparison of the average B factor for the l-Met molecules (28.5 Å2) and manganese ions (26.4
Å2) in the two MnMn(PfMetAP-II) molecules is lower than that of the average B factor for all other nonhydrogen atoms (34.5 Å2), indicating that the l-Met molecules and metal ions are present at high occupancy. The
two manganese atoms are 3.4 Å apart compared to 3.3 Å in the [CoCo(PfMetAP-II)] structure (Table 2 and Figure
7). The amino acid residues coordinated to the dinuclear MnII cluster are identical to those in the dinuclear
CoII structure with only minor perturbations in bond lengths and angles (Table 2 and Figure 7). Both Mn1 and
Mn2 reside in a distorted trigonal bipyramidal geometry, and the lack of observable electron density between
the two MnII ions suggests that the bridging water/hydroxide observed in the wild-type structure of
[CoCo(PfMetAP-II)] has been replaced by l-Met. l-Met binds to the dinuclear MnII active site, where one of the
carboxylate oxygen atoms binds to Mn1, while the N-terminal amine nitrogen atom binds to Mn2.

Figure 7 Active sites of (A) [CoCo(PfMetAP-II)] (PDB entry 1XGM), (B) [CoCo(EcMetAP-I)] complex with l-Met
(PDB entry 1C21), and (C) [MnMn(PfMetAP-II)]−l-Met. Color scheme for atoms are carbon, gray; oxygen, red;
nitrogen, blue; sulfur, yellow; cobalt, magenta; and manganese, orange.

Discussion
Recently, it was reported that both EcMetAP-I and PfMetAP-II contain a high- and low-affinity metal-binding site
and that each enzyme is maximally active when only one metal-binding site is occupied (18−20, 42). On the basis
of the observed catalytic activity and the metal-binding constants for both sites, both EcMetAP-I and PfMetAP-II
were proposed to function, in vivo, as a mononuclear enzyme. Additionally, the high-affinity metal-binding site
was assigned as the histidine-containing site and, therefore, is the catalytically relevant metal-binding site (19,
21). Recently, the human cytosolic AMPP, which has an identical active ligand to that of both EcMetAP-I
and PfMetAP-II, was shown to be maximally stimulated by MnII ions (43). Moreover, this study also showed that
only one MnII ion was required for full activity, providing the first evidence that AMPPs are also mononuclear
enzymes, similar to MetAPs. To gain insight into the MnII-binding properties and the product-bound forms of
both type-I and type-II MetAPs when MnII is the metal cofactor, we have recorded EPR spectra of the MnIIloaded forms of both enzymes.
The X-band EPR spectra of both [MnMn(EcMetAP-I)] and [MnMn(PfMetAP-II)] at 4 and 40 K exhibit a hyperfine
split six-line signal centered at g = 2 and with AI=5/2(55Mn) = 9 mT, characteristic of mononuclear MnII and
consistent with MnII ions being coordinated by oxygen- and nitrogen-containing ligands (32). In addition to the
mononuclear MnII signal, the parallel- and perpendicular-mode EPR spectra of both the naked and l-Met-bound
forms of [MnMn(EcMetAP-I)] and [MnMn(PfMetAP-II)] contain features that can only rationally be assigned to
spin-coupled MnII ions and indicate that a polynuclear MnII center can be formed in the enzyme. X-ray
crystallography shows that the enzyme can indeed form a dinuclear MnII center, and the EPR data are entirely
consistent with a proportion of the sample being a dinuclear MnII system. Attempts were made to extract spin
Hamiltonian parameters through computer simulations. Matrix diagonalization approaches have been successful

for both mononuclear MnII (44) and dinuclear MnII (39). In the present case, both the spectral and temperaturedependence resolution were insufficient to fully deconvolute spectral features. Thus, an accurate value for the
exchange coupling could not be obtained, and this parameter remained a variable in the simulations. The lack of
single-crystal data also dictated that the geometric relationships between the g tensors of the MnII ions and the
inter-MnII vector were unknown. An additional complication arises from the contribution of interdoublet
forbidden transitions, which are nonnegligible at the X band and require that simulations take into account all of
the S = 0, 1, 2, ..., 5 spin states simultaneously. The time required for each simulation of the dinuclear
component of the spectra of [MnMn(EcMetAP-I)] and [MnMn(PfMetAP-II)] is, therefore, measured in days
(weeks, if the hyperfine interaction is included) rather than minutes or hours. Because of the large numbers of
variables, exact line-shape simulations were not obtained but systematic variation of certain parameters was
carried out based on temperature dependence, crystallographic data, and earlier studies. The simulations
indicate an inter-MnII distance of 3.54 > r > 3.14 Å and thus provide support for the proposal that the EPR signal
is indeed due to the crystallographically identified dinuclear MnII center.
One of the steps within the proposed catalytic mechanism of MetAPs that has been largely overlooked is the
structure of the product-bound form of the enzyme. Initially, the electronic absorption spectrum of
[CoCo(PfMetAP-II)] was recorded both in the absence and presence of 120 mM l-Met. No change in the
λmax values was observed; however, the molar absorptivities decreased, suggesting that l-Met does bind to the
active-site CoII ions. The molar absorptivities of the [CoCo(PfMetAP-II)]−l-Met complex are consistent with
CoII coordination numbers of five. The fact that the CoII coordination number remains the same upon l-Met
binding suggests that l-Met displaces a labile CoII ligand, most likely a water/hydroxide. Conversely, the
previously reported electronic absorption spectrum of the [CoCo(EcMetAP-I)]−l-Met complex indicated that the
CoII coordination geometry changed from trigonal bipyramidal to distorted octahedral (13, 45). These data
suggest that, unlike the CoII centers in PfMetAP-II, the CoII centers in EcMetAP-I expanded their coordination
number.
The fact that the electronic absorption data suggest that l-Met binds differently to type-I MetAPs than type-II
MetAPs indicates that the two types of MetAPs may have some mechanistic differences. To further examine the
product-bound form of both type-I and type-II MetAPs, EPR spectra of [MnMn(EcMetAP-I)] and
[MnMn(PfMetAP-II)] in the presence of l-Met were recorded. Upon the addition of l-Met to [MnMn(EcMetAP-I)],
the signals observed at g = 2.4 and 1.7 become more intense than in the resting enzyme and exhibit a wellresolved eleven-line hyperfine splitting with A = 4.4 mT. These data are indicative of the formation of a dinuclear
MnII−MnII center that is magnetically coupled (Figure 4) (32, 38). These data suggest that the two MnII centers
are in close proximity within the MetAP active site, which allows magnetic coupling, or that there is a third
bridging moiety that facilitates such coupling. Interestingly, l-Met appears to increase either the resolution or
the relative amplitude of the multiline EPR signal because of dinuclear Mn, although it is unclear whether this is
due to an l-Met-mediated decrease in the lability of one or more of the Mn ions or whether l-Met binding
renders the multiline signal more easily observable because of the reduction of strains in the zero-field splitting
parameters. Further, the higher resolution of the hyperfine lines in the l-Met-bound forms may be indicative of a
reduction in the strain terms (either in g or in zero-field splitting parameters). The spectrum of
[MnMn(PfMetAP-II)]−l-Met also exhibits signals at g = 2.4 and 1.7, but the hyperfine pattern is not well-resolved
and is less pronounced, indicating that most of the MnII ions in the sample are uncoupled. Parallel-mode spectra
of the [MnMn(EcMetAP-I)]−l-Met and [MnMn(PfMetAP-II)]−l-Met complexes were also recorded (Figure 5 and
6). The parallel-mode spectrum of [MnMn(EcMetAP-I)]−l-Met exhibits a multiline signal at g = 7.6 with a
hyperfine coupling constant of 4.4 mT, indicative of a dinuclear MnII−MnII that is antiferromagnetically coupled.
This multiline pattern was not detected in the parallel-mode EPR spectrum of [MnMn(PfMetAP-II)]−l-Met. These
data are consistent with the suggestion that the dinuclear MnII center in PfMetAP-II is not as magnetically
coupled.

Figure 8 Omit Fo − Fc electron-density map calculated to 2.3 Å resolution for the [MnMn(PfMetAP-II)]−l-Met
complex (Table 1). Color scheme is same as in Figure 7.

Figure 9 Proposed catalytic mechanism for a dinuclear MnIIMetAP enzyme.
The observed EPR spectra of [MnMn(EcMetAP-I)]−l-Met and [MnMn(PfMetAP-II)]−l-Met contain signals with
similar g values, and these signals exhibit similar temperature dependencies. These data suggest that the
observed EPR signals originate from the same type of transition for both enzymes. The major difference arises
from the relative intensities of the respective signals assigned to the mono- and dinuclear MnII species in
[Mn(PfMetAP-II)]−l-Met and [MnMn(EcMetAP-I)]−l-Met (Figure 4). For example, the perpendicular-mode six-line
signal at g = 2.03 (A = 8.8 mT) is 3-fold more intense in [MnMn(PfMetAP-II)]−l-Met and has been shown to be
due to mononuclear MnII ions residing in octahedral or trigonal bipyramidal environments with oxygen or
nitrogen ligands (32). Similarly, in the parallel mode, the six-line hyperfine pattern observed at g = 4.2 with A =
8.8 is much better resolved and more pronounced in [MnMn(PfMetAP-II)]−l-Met than in [MnMn(EcMetAP-I)]−lMet. These data also suggest that the dinuclear MnII sites in type-I and type-II MetAPs in the presence of l-Met
reside in different environments, which results in an increased amount of mononuclear MnII sites in the
[MnMn(PfMetAP-II)]−l-Met complex.
To further characterize the binding of l-Met to [MnMn(PfMetAP-II)], the enzyme was crystallized in the presence
of l-Met and the X-ray crystal structure was determined to 2.3 Å resolution (Figures 7 and 8). Like all of the
structures reported for MetAP−inhibitor complexes, the methionine group of l-Met resides in a well-defined
hydrophobic pocket adjacent to the dinuclear MnII active site (13, 45). l-Met binding to [MnMn(PfMetAP-II)]
results in a species in which the Mn−Mn distance is 3.4 Å; the Co−Co distance in uncomplexed [CoCo(EcMetAPI)] is 3.3 Å. In both species, the coordination number remains five, consistent with the electronic absorption data
for [CoCo(EcMetAP-I)]. No active-site ligands are displaced upon l-Met binding except the water molecule, which
bridges the two CoII ions in the wild-type structure. This bridging water molecule is displaced by one of the
carboxylate oxygen atoms of l-Met. However, this carboxylate oxygen atom does not bridge between the two
MnII ions but is terminal on M1, consistent with the EPR data obtained on the [MnMn(PfMetAP-II)]−l-Met
complex. The N-terminal amine nitrogen of l-Met (N1) resides 2.1 Å from Mn2, indicating that it is bound to

Mn2. In both enzymes, the active-site histidine [His161 of PfMetAP-II (3.1 Å) and His178 of EcMetAP-I (2.6 Å)]
forms a hydrogen bond with the second oxygen of the carboxylate group of l-Met.
The observed binding mode of l-Met to [MnMn(PfMetAP-II)] is different from that reported for the binding of lMet to the active site of [CoCo(EcMetAP-I)] (Figure 7) (45). In the [CoCo(EcMetAP-I)]−l-Met structure, the
carboxylate oxygen atom of l-Met bridges between the two CoII centers, while the N-terminal amine nitrogen
atom binds to Co2. The observed differences in the X-ray crystal structures of [CoCo(EcMetAP-I)]−l-Met and
[MnMn(PfMetAP-II)]−l-Met likely account for the differences in magnetic coupling observed between
[MnMn(EcMetAP-I)]−l-Met and [MnMn(PfMetAP-II)]−l-Met. A bridging carboxylate oxygen, as observed in the
[CoCo(EcMetAP-I)]−l-Met structure, will provide a stronger magnetic coupling interaction for the two MnII ions,
with [MnMn(EcMetAP-I)]−l-Met accounting for the increased coupling between the two MnII ions in
[MnMn(EcMetAP-I)]−l-Met. The lack of a single atom bridge in the [MnMn(PfMetAP-II)]−l-Met structure
indicates that theses two MetAP enzymes bind the product differently.
On the basis of the data presented herein as well as all of the kinetic, spectroscopic, and X-ray crystallographic
data reported to date on MetAPs, a refined mechanism of action for EcMetAP-I and PfMetAP-II is proposed
(Figure 9) (45). On the basis of the recently proposed mechanism for the leucine aminopeptidase
from Aeromonas proteolytica (46, 47), the first step in catalysis for MetAPs is likely recognition of the N-terminal
methionine side chain by the hydrophobic pocket adjacent to the metalloactive site (13, 45). Next, the peptide
carbonyl oxygen coordinates to the histidine-ligated divalent metal ion. Hydrogen-bond formation between
His79 and the backbone N−H scissile peptide bond has been proposed based on X-ray crystallographic results,
thereby stabilizing the leaving group (13, 45). In addition, Glu204, which is also a ligand to the histidinecontaining divalent metal ion, was proposed to be a proton acceptor/donor in the catalytic process (13, 45).
Because the N-terminal amine nitrogen of the substrate forms a hydrogen bond with D97 based on X-ray
crystallography (13, 45), in the absence of a second metal ion, D97 likely assists to position the substrate
properly in the active site for formation of the transition-state intermediate (48). In the presence of a dinuclear
site, the second metal ion coordinates the N-terminal amine (13, 45). Next, the product-forming C−N bondbreaking step occurs followed by the release of the cleaved peptide. On the basis of the date presented herein,
the structure of the product-bound form of PfMetAP-II contains a single carboxylate oxygen atom bound to M1
with the N-terminal amine bound to M2. Moreover, this l-Met-binding mode is different from that observed
for l-Met binding [CoCo(EcMetAP-I)] (13, 45). Therefore, the catalytic mechanisms of type-I MetAPs may differ
somewhat from type-II enzymes; however, in the absence of a second metal ion, the proposed mechanisms for
type-I and type-II MetAPs would remain identical (48). The fact that the product, methionine, would be weakly
bound to Mn-loaded PfMetAP-II under physiological conditions is evidenced by its weak Ki (150 mM). Finally, the
active site adds two water molecules: one that binds to the divalent metal ion and one that bridges between
the coordinated water molecule and H178.
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